Pangaea

Pangaea Data is headquartered in London with offices in San Francisco and Hong Kong. Pangaea’s AI-driven software product, PIES, has proven to find 6x more suitable patients including those who are undiagnosed and miscoded, improve screening success rates by 400%, and save 90% in time by automatically generating clinical narratives for regulatory reports, from tables, figures, and listings. This is achieved through Pangaea's novel unsupervised Natural Language Processing (NLP) and first-of-its-kind Natural Language Generation (NLG) methods which respectively extract and summarize intelligence from textual and multi-modal health data at scale and in a federated privacy preserving manner. Through high impact peer reviewed publications, Pangaea's product has demonstrated 85 - 90% accuracy, which is transformatively higher than generic language models like GPT-3, supervised NLP, and relational extraction approaches. The founders at Pangaea have secured more than $200 million in research funding through their work. All customer success stories and peer-reviewed publications are available through Pangaea's website.